Completion rate and safety of non-invasive brain stimulation for upper limb dysfunction after stroke: a systematic review and network meta-analysis - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluation of Treatment Completion and Safety Profiles of Non-Invasive Brain Stimulation for Upper Limb Impairment Post-Stroke: A Systematic Review and Network Meta-Analysis

  • By

  • Juan Sun

  • ZiLe Wang

  • Yiming Huang

  • Yilin Du

  • Sijia Zhang

  • Hui Shen

  • Huimin Zhang

  • Shuxian Feng

  • September 9, 2026

Share

Objective:

To comprehensively assess and compare treatment completion rates across non-invasive brain stimulation (NIBS) modalities for upper limb rehabilitation in stroke patients.

Approach:
  • Statistical Analysis: Completion rates were pooled using random-effects single-arm meta-analyses with the Freeman-Tukey double arcsine transformation; Bayesian random-effects network meta-analysis estimated relative risks (RRs) and 95% credible intervals (CrIs).
Key Findings:
  • The overall pooled completion rate for NIBS interventions was 94.9%.
  • No NIBS intervention showed a statistically significant difference from sham/control in completion rates.
  • The adverse event (AE) rate across intervention groups was 16.4%, with mild headache and skin tingling being the most common.
  • Completion rates were higher for tDCS (96.8%) compared to rTMS (93.9%).
  • Chronic stroke phase had the highest completion rate (97.1%), while the mixed phase had the lowest (89.1%).
  • Intermittent theta burst stimulation (iTBS), bilateral rTMS (BL-rTMS), and dual transcranial direct current stimulation (Dual-tDCS) were the highest-ranked interventions.
Limitations:
  • The findings are hypothesis-generating rather than definitive due to minimal absolute completion-rate differences.
  • Four interventions were informed by only one study, limiting the robustness of the rankings.
  • Every pairwise credible interval included 1.00, indicating no clear superiority among interventions.
Conclusion:

Stroke phase may be an important consideration in designing adherence strategies.

Sources:

Original Source(s)

Related Content